heksa1
We were among first pharmaceutical companies in Croatia that successfully passed new licencing procedure aligned with EU regulatory requirements.
Good Distribution Practice
heksa4
whether of new innovative treatments or medicines of limited availability with new generic options.
Market Access
heksa3
and possess the in-depth knowledge of both national and joint European approval mechanisms.
Regulatory Affairs
heksa2
sales and marketing personnel of Makpharm has successfully launched a number products
Sales and marketing